Arundic acid (AA; ONO-2506), a novel modulator of astrocyte activation, may improve neuronal survival after stroke. We conducted a multicenter, dose-escalating, randomized, double-blind Phase I trial of AA in acute ischemic stroke. Subjects were randomized to treatment with AA or placebo in sequential dose tiers of 2-12 mg/kg/h (10-16 patients/group) within 24 h of stroke onset. Study drug was infused for 1 h daily over 7 days, and follow-up terminated at 40 days. Neurological and functional outcomes were evaluated through Day 40 as exploratory endpoints. A total of 92 subjects were enrolled with no dose-related pattern of serious adverse events (AEs). Premature terminations caused by AEs occurred in four (8.2%) patients treated with AA and five (11.6%) treated with placebo. Two subjects treated with AA (4.1%) and four given placebo (9.3%) died. Exploratory efficacy analysis showed a trend toward improvement in the change from baseline National Institutes of Health Stroke Scale (NIHSS) in the 8 mg/kg/h AA group on Days 3 (p=0.023 vs. placebo), 7 (p=0.002), 10 (p=0.003), and 40 (p=0.018). A dose of 8 mg/kg/h AA produced a favorable trend in reduction of NIHSS that should be confirmed in a future clinical trial.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jns.2006.09.001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
1,25-dihydroxyvitamin D3 regulates enteroglial bioactivity through butyric acid pathway in a high-fat diet mouse model.
J Steroid Biochem Mol Biol
December 2024
The First Clinical Medical College, Guangdong Medical University, China; Department I of Gastrointestinal Surgery, Affiliated Maoming Hospital, Southern Medical University, China; Department I of Gastrointestinal Surgery, Maoming People's Hospital, Maoming City, China.
1,25-dihydroxyvitamin D3 (1,25(OH)2D3), affects enteric glial cells (EGCs) activity, but the mechanism is still unknown. The current study aimed to explore whether 1,25(OH)2D3 could regulate EGCs activity via butyrate pathway in a high-fat diet model. Male C57BL/6 J mice were fed with standard diet (SDD), or vitamin-D-deficient diet (VDD), or high-fat diet (HFD), or HFD plus sodium butyrate (SBR), or HFD plus 1,25(OH)2D3, or HFD plus S100B inhibitor ONO-2506 in vivo.
View Article and Find Full Text PDFPersistence of post-stress blood pressure elevation requires activation of astrocytes.
Sci Rep
October 2024
Clinical Research Center, Murayama Medical Center, 2-37-1 Gakuen, Musashimurayama, Tokyo, 208-0011, Japan.
Article Synopsis
- The sympathetic nervous system reacts to psychological stress by raising blood pressure, a condition that can persist even after the stress is gone, potentially contributing to hypertension.
- Researchers investigated how astrocytes, a type of brain cell, influence this ongoing rise in blood pressure using arundic acid, an inhibitor of astrocytes.
- The study found that arundic acid reduced the blood pressure increase caused by stress in rats, indicating that both neurons and astrocytes are important in understanding stress-related hypertension.
Enantioselective Nickel-Electrocatalyzed Reductive Propargylic Carboxylation with CO.
J Am Chem Soc
May 2024
Hefei National Research Center for Physical Sciences at the Microscale and Department of Chemistry, University of Science and Technology of China, Hefei 230026, China.
Article Synopsis
- The text discusses the use of carbon dioxide (CO) as a sustainable source for creating specific carboxylic acids through a new electrochemical reaction.
- A nickel catalyst is employed to efficiently facilitate this process without needing moisture-sensitive chemicals, allowing for the formation of carbon-carbon (C-C) bonds.
- This method has shown high efficacy, reaching up to 98% in terms of the purity of the desired product, and has been applied in the total synthesis of various complex organic molecules, highlighting its potential in sustainable chemistry.
Catalytic stereodivergent allylic alkylation of 2-acylimidazoles for natural product synthesis.
Nat Commun
December 2023
Hefei National Research Center for Physical Sciences at the Microscale and Department of Chemistry, University of Science and Technology of China, Hefei, 230026, China.
The stereocontrolled allylic alkylation of carbonyl compounds with the goal of producing the full range of stereoisomers presents an effective approach for increasing the productivity of collective natural product synthesis and the creation of chiral molecule libraries for drug exploration. The simultaneous control of regio-, diastereo-, and enantioselectivity poses a significant synthetic challenge in contemporary organic synthesis. Herein, we describe a catalytic stereodivergent α-allylation protocol applicable to both aliphatic and aromatic 2-acylimidazoles, thereby providing a practical blueprint for the divergent synthesis of important chiral building blocks.
View Article and Find Full Text PDFSpinal astrocyte dysfunction drives motor neuron loss in late-onset spinal muscular atrophy.
Acta Neuropathol
May 2023
Department of Neurology, Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.
Spinal muscular atrophy (SMA) is a progressive neuromuscular disorder caused by a loss of the survival of motor neuron 1 (SMN1) gene, resulting in a loss of spinal motor neurons (MNs), leading to muscle weakness and wasting. The pathogenesis of MN loss in SMA and the selective vulnerability in different cellular populations are not fully understood. To investigate the role of spinal astrocytes in the pathogenesis of late-onset SMA, we used a mouse model in addition to in vitro approaches.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!